Biotech · Private company
Plexxikon
Track this companyFree. Adds Plexxikon to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials11
- Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHDPHASE1_PHASE2 · TERMINATED · started Apr 19, 2022ClinicalTrials.gov NCT04910152 · fetched Nov 12, 2026
- A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jul 2, 2015ClinicalTrials.gov NCT02452424 · fetched Nov 12, 2026
- CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid TumorsPHASE1_PHASE2 · COMPLETED · started Mar 6, 2015ClinicalTrials.gov NCT02401815 · fetched Nov 12, 2026
- A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF MelanomaPHASE1 · TERMINATED · started Nov 5, 2013ClinicalTrials.gov NCT01826448 · fetched Nov 12, 2026
- A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed GlioblastomaPHASE1_PHASE2 · COMPLETED · started Jul 18, 2013ClinicalTrials.gov NCT01790503 · fetched Nov 12, 2026
- Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)PHASE2 · TERMINATED · started May 25, 2012ClinicalTrials.gov NCT01499043 · fetched Nov 12, 2026
- Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started May 1, 2012ClinicalTrials.gov NCT01525602 · fetched Nov 12, 2026
- A Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaPHASE2 · TERMINATED · started Dec 3, 2011ClinicalTrials.gov NCT01349036 · fetched Nov 12, 2026
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)PHASE1_PHASE2 · COMPLETED · started Nov 21, 2011ClinicalTrials.gov NCT01349049 · fetched Nov 12, 2026
- Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin LymphomaPHASE2 · COMPLETED · started Mar 3, 2011ClinicalTrials.gov NCT01217229 · fetched Nov 12, 2026
- Safety Study of PLX108-01 in Patients With Solid TumorsPHASE1 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT01004861 · fetched Nov 12, 2026